Knock-in Rat Models

CRISPR-Cas9 or a related genome-editing tool creates a targeted break at a selected genomic location. A donor DNA template then guides the cell’s repair process, allowing the desired sequence to be inserted at that site. This coordinated use of a break and template supports the placement of disease-associated variants, human gene sequences, or reporters in a defined genetic context.

The donor template specifies what genetic material should be incorporated during repair of the targeted DNA break. Its sequence can encode a disease-associated mutation, a human gene sequence, or a reporter. Because the template directs the intended insertion, it determines which allele researchers can examine and what genetic change will be related to the resulting phenotype.

Knock-in Rat Models provide a controlled genetic change at a defined genomic location. Naturally occurring variants may not offer the same control over the sequence or its position, while broader transgenic approaches can differ in how the introduced material is incorporated. This targeted design helps researchers more directly connect one selected allele with physiological traits or disease-related mechanisms.

The workflow begins by selecting the genomic location and desired allele, such as a mutation, human sequence, or reporter. Genome-editing tools then create a targeted DNA break, and a donor template supplies the sequence intended for insertion. Repair incorporates that sequence at the chosen site, producing rats in which the selected genetic change can be studied.

Researchers may choose these models when they need to examine how a specific allele affects an intact animal rather than studying the sequence only in isolation. The approach supports investigation of gene function, disease mechanisms, therapeutic targets, and drug responses. It is especially useful when the research question depends on connecting a defined genetic alteration with physiological traits.

These models can help link a precisely selected mutation or introduced sequence to physiological traits observed in the rat. They also support studies of disease mechanisms, evaluation of potential therapeutic targets, and assessment of drug responses. In this way, the genetic change serves as a controlled experimental variable for interpreting whole-animal effects in genetics research.